Entrepreneurship at Rutgers University

Rutgers' entrepreneurship advantage is its position between two of the largest startup ecosystems in the country: New York City and Philadelphia. New Brunswick is a one-hour train ride from Penn Station in Manhattan and a similar distance from Philadelphia, giving Rutgers founders access to investors, customers, and talent in both markets. The Rutgers Business School has invested in entrepreneurship through the Center for Urban Entrepreneurship and Economic Development (CUEED) and the I-Corps program, and the university's $900 million annual research expenditure creates commercializable technology across engineering, pharmacy, biotech, and food science.

Rutgers' particular strengths in pharmaceutical sciences (the Ernest Mario School of Pharmacy is one of the best in the country), food science, and environmental science create startup opportunities in pharma tech, food tech, and sustainability that leverage the university's research excellence. The New Jersey Innovation Institute (NJII) connects university research to commercial applications, and the Rutgers EcoComplex in South Jersey provides space for clean energy and environmental startups.

New Jersey itself has a concentrated pharmaceutical industry presence (Johnson & Johnson, Merck, Bristol-Myers Squibb are all headquartered in the state), which creates enterprise customers and partnership opportunities for healthtech and pharma tech startups. The state's VC ecosystem, while smaller than New York's, includes firms like Edison Partners and TechUnited that focus on regional investments.

Rutgers student founders in 2026 benefit from the university's scale (over 70,000 students across all campuses) and its strategic position between NYC and Philadelphia. The I-Corps program provides customer discovery training, and the Rutgers Venture Fund invests in university-affiliated startups. The New Brunswick Innovation Center provides incubation space for early-stage companies.

The practical advantage is geographic optionality: Rutgers founders can access NYC's capital and customer markets, Philadelphia's growing startup scene, and New Jersey's pharmaceutical and financial services industries, all while operating from a lower-cost New Jersey base.

• Center for Urban Entrepreneurship and Economic Development (CUEED)
• Rutgers Business School - entrepreneurship programs
• I-Corps at Rutgers - customer discovery training
• Rutgers Innovation and Entrepreneurship Initiative

• New Brunswick Innovation Center
• New Jersey Innovation Institute (NJII)
• Rutgers EcoComplex - clean energy and environment

• Rutgers Entrepreneurship Society
• Scarlet Startups
• Rutgers Venture Fund
• Rutgers Business Plan Competition team

• J&J (James Wood Johnson)
• Celgene (Sol Barer)
• Audible (Don Katz)
• Integra LifeSciences

Rutgers founders operate in a corridor between two of the largest business markets in the US. The NJ Transit train puts them in Manhattan in about an hour and in Philadelphia in a similar timeframe, creating dual-market access that few universities can match. New Jersey's pharmaceutical industry concentration means that pharma tech and healthtech founders have potential enterprise customers within driving distance. The New Brunswick Innovation Center and NJII provide local incubation, while the broader NYC and Philadelphia ecosystems provide access to capital and talent for scaling. The cost advantage of New Jersey over Manhattan is significant, particularly for startups that need lab or office space.

New Brunswick is between NYC and Philadelphia, giving access to both ecosystems. New Jersey has a concentrated pharmaceutical industry and growing tech presence. Edison Partners and TechUnited provide regional VC.